antenatal screening programme
T18 and T13
Edwards' Syndrome (Trisomy 18) and Patau’s syndrome (Trisomy 13) are rare but very serious conditions which affect a small number of babies every year. They are caused (like Down’s syndrome) by the baby having an incorrect number of chromosomes in every cell. Chromosomes are structures that carry important information that determine how we develop.
Read more about T18 and T13 on the NHS website.
UK NSC screening recommendation
Following the review of cfDNA (also known as NIPT) screening in pregnancy, an evaluation was recommended into its introduction because:
- an invasive diagnostic test carries a small risk of miscarriage. The evidence suggests that NIPT will reduce the number of women being offered an invasive test
- however, while we know that the accuracy of NIPT is very good, we don’t yet know how it will perform in an NHS screening programme pathway
- for women who choose to have NIPT, this will add in an extra step in the screening programme. The impact of this, and the choices women make at different points in the pathway, is something that we hope to gain a better understanding of through further research and evaluation
The UK NSC has recommended evaluating the introduction of non-invasive prenatal testing (NIPT) to Down's syndrome screening. This will include scientific, ethical and user input to better understand the impact on women, their partners and the screening programme around the offer of cfDNA or invasive testing following a screening test result where:
- the screening test risk score for trisomy 21 (T21) is greater than or equal to 1 in 150
- the combined test risk score for trisomy 18 (T18) and trisomy 13 (T13) is greater than or equal to 1 in 150
Supporting documents from the 2016 review
Evidence summary T18 and T13 (2015)
This document provides the evidence on which the current UK NSC recommendation is based.
Coversheet
This document summarises the review process including the public consultation comments.
Screening around the UK
The UK NSC recommends screening for this condition, however this may vary slightly depending on where you are in the UK.
Review cycle
Date previous review completed: 2016
Next review estimated to be completed: 2021 to 2022.
To see previous evidence reviews, visit the UK NSC archive.
Organisations interested in T18 and T13
These organisations have expressed interest in this recommendation and may submit responses to evidence reviews.
List of organisations
- Antenatal Results and Choices
- BLISS
- British Heart Foundation
- British Pregnancy Advice Service
- CDH UK
- Child Growth Foundation
- Children's Heart Federation
- CLAPA
- Contact a Family
- CRUSE
- DIPex
- Down's Heart Group
- Down's Syndrome Association
- Down's syndrome Medical Interest Group
- Down Syndrome Education International
- Down Syndrome Research Foundation UK
- Elfrida Society
- Faculty of Public Health
- Genetic Alliance UK
- Little Hearts Matter
- Marie Stopes International
- MENCAP
- PHG Foundation
- Restricted Growth Foundation
- Royal College of General Practitioners
- Royal College of Midwives
- Royal College of Obstetricians and Gynaecologists
- Royal College of Physicians
- Royal College of Physicians and Surgeons of Glasgow
- Royal College of Physicians of Edinburgh
- SHINE Charity
- Sickle Cell Society
- Society of Radiographers
- SOFT
- Stillbirth and Neonatal Death Charity
- Tiny Tickers
- Together for Short Lives
- Wolfson Institute of Preventive Medicine
If you think your organisation should be added, please contact us.